Article info
PDFClinical and epidemiological research
Extended report
A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease
- Correspondence to Dr Ronald M Laxer, Division of Rheumatology, The Hospital for Sick Children, Department of Paediatrics University of Toronto, Toronto, Ontario, Canada; ronald.laxer{at}sickkids.ca
Citation
A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease
Publication history
- Received September 18, 2017
- Revised December 15, 2017
- Accepted December 23, 2017
- First published January 9, 2018.
Online issue publication
April 12, 2018
Article Versions
- Previous version (9 January 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.